CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 788

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 15.69%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 57.77%
Services
Technology
Transportation
Utilities

75 Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held ▲
AGIOS PHARMACEUTICALS INC COM -10,669 Sold Out 0
ALNYLAM PHARMACEUTICALS INC COM -6,069 Sold Out 0
ARROWHEAD RESH CORP COM NEW -6,399 Sold Out 0
CLOVIS ONCOLOGY INC COM -6,369 Sold Out 0
JAZZ PHARMACEUTICALS PLC SHS USD -18,992 Sold Out 0
ZS PHARMA INC COM -2,108 Sold Out 0
SAGE THERAPEUTICS INC COM 61 -552 (90) 1,000
NEVRO CORP COM 537 537 New 10,000
PTC THERAPEUTICS INC COM 710 -8,164 (92) 10,000
BELLICUM PHARMACEUTICALS INC COM 1,557 1,557 New 60,000
APPLIED GENETIC TECHNOL CORP COM 1,325 New 60,600
AVALANCHE BIOTECHNOLOGIES INC COM 2,736 New 65,000
EPIRUS BIOPHARMACEUTICALS INC COM 709 709 New 75,000
CHINA BIOLOGIC PRODS INC COM 8,793 -489 (5.26) 90,000
AUSPEX PHARMACEUTICALS INC COM 10,066 New 100,000
SCYNEXIS INC COM 893 New 100,000
SYNAGEVA BIOPHARMA CORP COM 10,596 New 100,000
VERACYTE INC COM 884 884 New 100,200
AKEBIA THERAPEUTICS INC COM 1,023 -2,445 (70.5) 118,000
ULTRAGENYX PHARMACEUTICAL INC COM 7,800 New 120,000